Coverage
-
April 27, 2015
A medical device maker ordered by a Delaware federal jury in 2013 to pay a Johnson & Johnson Inc. subsidiary $16 million for infringing on three medical patents argued Friday that an opposition witness's falsified credentials cast enough doubt on the outcome to justify a new trial.
2 other articles on this case.
View all »